GLP-2 T (Tirzepatide) is a dual agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, amplifying the effects of both incretin hormones. This dual action enhances insulin secretion, reduces glucagon levels, and improves glucose regulation more effectively than single-pathway agonists. Additionally, GLP-2 T’s influences metabolic signaling pathways to support energy balance and lipid metabolism, contributing to improved nutrient processing and storage.
 
Key Characteristics and Functions:
 
Appetite Regulation: By acting on GLP-1 receptors in the hypothalamus and other brain regions associated with appetite control, semaglutide reduces food intake and promotes satiety.
 
Body Weight Reduction: Through its effects on appetite and potentially other metabolic pathways, semaglutide has been shown to facilitate significant weight loss in clinical studies.
 
Cardiovascular Effects: Research indicates that semaglutide may have beneficial effects on cardiovascular risk factors, including improvements in lipid profiles and blood pressure.